My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Xencor, Inc. - Common Stock (NQ:XNCR)

15.57 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xencor, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Top 5 Health Care Stocks That May Collapse In February ↗

February 13, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Xencor to Present at the SVB Securities Global Biopharma Conference

February 07, 2023

From Xencor, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023 ↗

January 31, 2023

Via Benzinga

Why Shares of Zencor Rose This Week ↗

January 26, 2023

The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago.

Via The Motley Fool

3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023

January 13, 2023

Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.

Via MarketBeat

Xencor's Return On Capital Employed Overview ↗

December 01, 2022

Via Benzinga

Xencor's Return On Capital Employed Overview ↗

August 11, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023 ↗

January 30, 2023

Via Benzinga

Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates

January 09, 2023

From Xencor, Inc.

Via Business Wire

Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023

From Xencor, Inc.

Via Business Wire

Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting

December 12, 2022

From Xencor, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

Xencor to Present at Upcoming Investor Conferences

November 10, 2022

From Xencor, Inc.

Via Business Wire

Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb® Programs at the SITC Annual Meeting

November 10, 2022

From Xencor, Inc.

Via Business Wire

Xencor Reports Third Quarter 2022 Financial Results

November 07, 2022

From Xencor, Inc.

Via Business Wire

Xencor’s IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study

November 07, 2022

From Xencor, Inc.

Via Business Wire

Earnings Scheduled For November 7, 2022 ↗

November 07, 2022

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.

Via Benzinga

Xencor Earnings Preview ↗

November 04, 2022

Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report an...

Via Benzinga

Xencor to Present New Clinical Data from the Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin’s Lymphoma at the American Society of Hematology Annual Meeting

November 03, 2022

From Xencor, Inc.

Via Business Wire

Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022

October 31, 2022

From Xencor, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗

October 13, 2022

Upgrades

Via Benzinga

Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting

October 05, 2022

From Xencor, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 ↗

September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...

Via Benzinga

Xencor Appoints Nancy Valente, M.D., to Board of Directors

September 09, 2022

From Xencor, Inc.

Via Business Wire

Xencor Reports Second Quarter 2022 Financial Results

August 03, 2022

From Xencor, Inc.

Via Business Wire

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022

July 27, 2022

From Xencor, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

June 13, 2022

During Monday's trading, 1214 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 10, 2022

On Friday, 422 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.